← Open Payments lookup

LAURA BRADIGAN: Open Payments

NPI 1407464522 · COMPTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,105 in 49 payments from 15 companies in 2025. Trend: 2023 $3,166 · 2024 $4,401 · 2025 $1,105

Food & beverage: $1,099Education: $5
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc10$210
Neurocrine BioSciences, Inc.6$165
ABBVIE INC.7$150
Vanda Pharmaceuticals Inc.6$124
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$89
Alkermes, Inc.4$85
Otsuka America Pharmaceutical, Inc.3$65
E.R. Squibb & Sons, L.L.C.2$34
Corium, LLC1$34
Teva Pharmaceuticals USA, Inc.1$32

Products named: INGREZZA, VRAYLAR, SPRAVATO, FANAPT, REXULTI, CAPLYTA, ARISTADA, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.